MAPT and Alzheimer disease: As additional proof of concept, we assessed whether our method would recapitulate the pathology of advanced Alzheimer’s disease (AD), typically characterized by widespread cortical neuronal loss and gliosis, accompanied by tau and amyloid-beta deposition [15].